Advertisement
Australia markets close in 3 hours 14 minutes
  • ALL ORDS

    8,485.40
    +41.70 (+0.49%)
     
  • ASX 200

    8,215.40
    +38.50 (+0.47%)
     
  • AUD/USD

    0.6744
    -0.0006 (-0.09%)
     
  • OIL

    74.02
    +0.45 (+0.61%)
     
  • GOLD

    2,640.70
    +5.30 (+0.20%)
     
  • Bitcoin AUD

    92,609.53
    -251.44 (-0.27%)
     
  • XRP AUD

    0.79
    +0.00 (+0.24%)
     
  • AUD/EUR

    0.6143
    +0.0001 (+0.01%)
     
  • AUD/NZD

    1.1042
    +0.0050 (+0.45%)
     
  • NZX 50

    12,751.82
    +195.83 (+1.56%)
     
  • NASDAQ

    20,107.78
    +307.04 (+1.55%)
     
  • FTSE

    8,190.61
    -113.01 (-1.36%)
     
  • Dow Jones

    42,080.37
    +126.13 (+0.30%)
     
  • DAX

    19,066.47
    -37.63 (-0.20%)
     
  • Hang Seng

    21,281.95
    +355.16 (+1.70%)
     
  • NIKKEI 225

    39,314.08
    +376.54 (+0.97%)
     

Analysts Just Made A Major Revision To Their Swiss Life Holding AG (VTX:SLHN) Revenue Forecasts

The latest analyst coverage could presage a bad day for Swiss Life Holding AG (VTX:SLHN), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative.

Following the latest downgrade, the six analysts covering Swiss Life Holding provided consensus estimates of CHF17b revenue in 2023, which would reflect a stressful 22% decline on its sales over the past 12 months. Statutory earnings per share are anticipated to drop 19% to CHF39.15 in the same period. Prior to this update, the analysts had been forecasting revenues of CHF20b and earnings per share (EPS) of CHF40.76 in 2023. Indeed, we can see that analyst sentiment has declined measurably after the new consensus came out, with a measurable cut to revenue estimates and a small dip in EPS estimates to boot.

Check out our latest analysis for Swiss Life Holding

earnings-and-revenue-growth
SWX:SLHN Earnings and Revenue Growth January 13th 2024

Analysts made no major changes to their price target of CHF611, suggesting the downgrades are not expected to have a long-term impact on Swiss Life Holding's valuation.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. Over the past five years, revenues have declined around 2.2% annually. Worse, forecasts are essentially predicting the decline to accelerate, with the estimate for an annualised 39% decline in revenue until the end of 2023. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 5.8% per year. So while a broad number of companies are forecast to grow, unfortunately Swiss Life Holding is expected to see its sales affected worse than other companies in the industry.

The Bottom Line

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Swiss Life Holding. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Swiss Life Holding's revenues are expected to grow slower than the wider market. Overall, given the drastic downgrade to this year's forecasts, we'd be feeling a little more wary of Swiss Life Holding going forwards.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for Swiss Life Holding going out to 2026, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.